Hermed Capital Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 6

Professionals
  • Investments
  • 13

  • Portfolio
  • 10

  • Exits
  • 3

Exits

Hermed Capital General Information

Description

Hermed Capital is a private equity and venture capital firm that invests in the healthcare industry. The firm prefers to invest in companies within the pharmaceuticals, medical device and diagnostic and medical services sectors. Hermed Capital is based in Shanghai, China.

Contact Information

Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Other Investor Types
Growth/Expansion
Primary Office
  • Room.308, Building A
  • Number 1289, Yishan Road
  • Shanghai
  • China
+86 00000000000

Hermed Capital Investments (13)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Aubrak Therapeutics 25-Mar-2022 Early Stage VC 000.00 Drug Discovery Clinical Trials - General
00000 04-Jan-2022 00000 00000 0000 Drug Discovery Generating Revenue
0000000000 02-Dec-2020 00 000000000 0000 Therapeutic Devices Generating Revenue
000000 00000000000 24-Aug-2020 00000 00000 0000 Drug Discovery Clinical Trials - Phase 3
0000000000 02-Oct-2019 00 000000000 000.00 Surgical Devices Generating Revenue 0000 000000 00.0
000000 00000000000 26-Jul-2019 00000 00000 0000 Drug Discovery Clinical Trials - Phase 3
0000000 000000 03-Nov-2017 00000 00000 000.00 Enterprise Systems (Healthcare) Generating Revenue
0000 0000000000 08-May-2017 00000 00000 0000 Drug Discovery Generating Revenue/Not Profitable 0000 000000 00.0
Epic Sciences 28-Apr-2017 Later Stage VC 0000 Biotechnology Generating Revenue 0000 000000 00.0
Chigene 03-Dec-2016 Early Stage VC 000.00 Decision/Risk Analysis Generating Revenue
You’re viewing 10 of 13 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Hermed Capital Exits (3)

Company Name Exit Date Exit Type Exit Size
Hinova Pharmaceuticals 12-Apr-2022 IPO 00000
0000 0000000000 27-Aug-2021 0000000 000000
000000000 00000000 000000000 00000000
To view Hermed Capital’s complete exits history, request access »

Hermed Capital Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Hermed Capital Team (9)

Name Title Deals Funds Boards Office
Xiao Zhenyu Ph.D Managing Director 0 0 0 Shanghai, China
Qiang Zhao Financial Director Shanghai, China
Garry Gong Investment Director Shanghai, China
Hanson Wu Investment Director Shanghai, China
Tony Yan Vice-Investment Director Shanghai, China
You’re viewing 5 of 9 team members. Get the full list »

Hermed Capital Co-Investors (20)

Name With Exits Lead Partner Series Industry
Delta Capital 1 Series chart Industry bar
Fosun Pharma 0 0 Series chart Industry bar
Highlight Capital 0 Series chart Industry bar
Power Capital 0 0 Series chart Industry bar
Suzhou Guofa Venture Capital 0 0 Series chart Industry bar
You’re viewing 5 of 20 co-investors. Get the full list »